Clinical
Trials
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
-
Study to Evaluate Efficacy and Safety of Zanubrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Condition:
Lymphoma
Molecule:Zanubrutinib
-
Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Condition:
Leukemia, Lymphoma
Molecule:Zanubrutinib
-
A Study to Investigate Zanubrutinib in Chinese Patients With B-cell Lymphoma
Condition:
Lymphoma
Molecule:Zanubrutinib
-
Study of the Safety and Pharmacokinetics of Zanubrutinib in Subjects With B-Cell Lymphoid Malignancies
Condition:
Lymphoma, Leukemia, Myeloma
Molecule:Zanubrutinib
-
Zanubrutinib in Combination With Tislelizumab in Subjects With B-cell Malignancies
Condition:
Lymphoma, Leukemia
Molecule:Zanubrutinib + Tislelizumab
-
Comparison of Efficacy and Safety of Tislelizumab Versus Docetaxel as Treatment in the Second- or Third-line Setting in Patients With Non-Small Cell Lung Cancer (NSCLC)
Condition:
Lung Cancer
Molecule:Tislelizumab
-
A Study of Tislelizumab Versus Chemotherapy as Second Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma (ESCC)
Condition:
Esophageal Cancer
Molecule:Tislelizumab
-
Phase 3 Study of Tislelizumab Versus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Condition:
Liver Cancer
Molecule:Tislelizumab
-
Study of Tislelizumab in Patients With Previously Treated Unresectable Hepatocellular Carcinoma (HCC)
Condition:
Liver Cancer
Molecule:Tislelizumab
-
A Study of Tislelizumab in Patients With Relapsed or Refractory Mature T- and NK- Neoplasms
Condition:
Lymphoma
Molecule:Tislelizumab
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.